Rockefeller Capital Management
FBIO icon

Rockefeller Capital Management’s Fortress Biotech FBIO Stock Holding History

Rockefeller Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
4,812
– – ﹤0.01% 3849
2026
Q1 		$13.4K Buy
+4,812
New +$16.4K ﹤0.01% 3863
2025
Q4 		– Sell
-4,812
Closed -$17.8K – 4717
2025
Q3 		$17.8K Buy
+4,812
New +$12.2K ﹤0.01% 3405

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rockefeller Capital Management's FBIO Position: Q2 2026 in Review

Rockefeller Capital Management held its Fortress Biotech (FBIO) position steady in Q2 2026 at 4,812 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3849.

Rockefeller Capital Management first reported a position in FBIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $17.8K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Rockefeller Capital Management held 4,812 shares of Fortress Biotech worth $14.7K as of Q2 2026.
  • Rockefeller Capital Management left its Fortress Biotech share count unchanged in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3849 holding.
  • Rockefeller Capital Management first reported a position in Fortress Biotech in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Fortress Biotech position peaked at $17.8K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.